Richard Barfield (CFO) Presenting at the Proactive One2One virtual forum Ergomed is a global provider of expert, high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO). The Ergomed group employs over 1,200 people and operates out of 24 offices around the world, providing its services in around 100 countries globally.
Ergomed (LON:ERGO) Presenting at the Proactive One2One virtual forum - October 2021
